about
Mesoblast Ltd is a commercial-stage biotechnology company and a world leader in developing allogeneic (off-the-shelf) cellular medicines for the treatment of severe and life-threatening inflammatory conditions. The company's product candidates includ...
Read More
14.37
-0.56
(-3.75%)
146.6K
XNAS Volume
XNAS 07 Nov, 2025 1:44 PM (EST)
Board Meeting
The next board meeting for Mesoblast Ltd - ADR is on 14 Nov 2025 for the purpose of Mesoblast Ltd Annual General Meeting for 2025
See details
Not Eligible
Expensive Valuation
Technically Neutral
Mesoblast ADR Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..